Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Akalin, Altuna Dr. (1) Birchmeier-Kohler, Carmen Prof. Dr. (2) Bunse, Mario Dr. (1) Clauß, Julian (1) Costanza, Mariantonia Dr. (1) Daniel, Peter Prof. Dr. (1) Diecke, Sebastian Dr. (1) Gerhardt, Holger Prof. Dr. (1) Haucke, Volker Professor (1) Hinze, Christian Dr. med. Dipl.-Math. (1) Höpken, Uta Elisabeth PD Dr. (1) Ivics, Zoltan Dr. (1) Izsvak, Zsuzsanna Dr. (1) Janz, Martin Dr. (5) Kastelic, Nicolai (1) Kempa, Stefan Dr. (1) Kieback, Elisa Dr. (1) Kirchner, Marieluise Dr. (2) Kühn, Ralf Dr. (1) Landthaler, Markus Prof. Dr. (1) Leisegang, Matthias Prof. Dr. rer. nat. (2) Lewin, Gary Prof. Dr. (1) Lusatis, Simone (1) Mathas, Stephan Dr. (5) Na, Il-Kang Dr. (1) Rehm, Armin Dr. (1) Rudolph, Ina-Maria Dr. (1) Scheidereit, Claus Prof. Dr. (1) Sczakiel, Henrike (1) Selbach, Matthias Prof. Dr. (8) Stein, Ulrike Prof. Dr. (1) Uckert, Wolfgang Prof. Dr. (3) Uyar, Bora Dr. (1) Walther, Wolfgang Prof. Dr. (2) Willimsky, Gerald Dr. (3) Willnow, Thomas Prof. Dr. (1) Zauber, Henrik Dr. (3) (-) Blankenstein, Thomas Prof. Dr. (12) (-) Wollert-Wulf, Brigitte (2) (-) Biologie maligner Lymphome (2) Genetik und Genomik von Herz- Kreislauferkrankungen (1) Immundysregulationen in der Onkologie (1) Immunregulation und Krebs (1) (-) Molekulare Immunologie und Gentherapie (12) Systembiologie von Gen-regulatorischen Elementen (1) 1992 (4) (-) 1993 (7) 1994 (5) 1995 (8) 1996 (6) 1997 (9) 1998 (9) 1999 (2) 2000 (8) 2001 (5) 2002 (5) 2003 (9) 2004 (8) 2005 (10) (-) 2006 (3) 2007 (5) 2008 (5) 2009 (2) 2010 (7) 2011 (5) 2012 (6) 2013 (13) 2014 (4) 2015 (4) 2016 (4) 2017 (6) (-) 2018 (4) 2019 (6) 2021 (4) 2022 (6) 2023 (6) 2024 (2) 14 Ergebnisse: Active Filter: Blankenstein, Thomas Prof. Dr.Wollert-Wulf, BrigitteBiologie maligner LymphomeMolekulare Immunologie und Gentherapie 199320062018 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. November 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert 01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken 15. März 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou 30. August 2018 / Blood Oncogene-specific T cells fail to eradicate lymphoma-initiating B cells in mice D. Hoser C. Schön C. Loddenkemper P. Lohneis A.A. Kühl T. Sommermann T. Blankenstein G. Willimsky 01. Juni 2018 / Cancer Res ERAP1-dependent antigen cross-presentation determines efficacy of adoptive T cell therapy in mice K. Schmidt C. Keller A.A. Kühl A. Textor U. Seifert T. Blankenstein G. Willimsky P.M. Kloetzel 01. August 2018 / Clin Cancer Res Targeting Merkel cell carcinoma by engineered T cells specific to T-antigens of Merkel cell polyomavirus I. Gavvovidis M. Leisegang G. Willimsky N.J. Miller P. Nghiem T. Blankenstein 01. Januar 2018 / Cancer Immunol Res A transgenic dual-luciferase reporter mouse for longitudinal and functional monitoring of T cells in vivo M. Szyska S. Herda S. Althoff A. Heimann J. Russ D. D'Abundo T.M. Dang I. Durieux B. Dörken T. Blankenstein I.K. Na 01. August 1993 / Br J Haematol Lymphotoxin, tumour necrosis factor and interleukin-6 gene transcripts are present in Hodgkin and Reed-Sternberg cells of most Hodgkin's disease cases H.D. Foss H. Herbst E. Oelmann J. Samol M. Grebe T. Blankenstein J. Matthes Z. Qin B. Falini S. Pileri T. Diamantstein H. Stein 15. September 1993 / Canc Res Interleukin 10 transfected into Chinese hamster ovary cells prevents tumor growth and macrophage infiltration G. Richter S. Krueger-Krasagakes G. Hein C. Huels E. Schmitt T. Diamantstein T. Blankenstein 01. Juli 1993 / J Exp Med Expression of tumor necrosis factor by different tumor cell lines results either in tumor suppression or augmented metastasis Z. Qin S. Krueger-Krasagakes U. Kunzendorf H. Hock T. Diamantstein T. Blankenstein Seitennummerierung Aktuelle Seite 1 Seite 2 Nächste Seite Next › Letzte Seite Last »
01. November 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert
01. Februar 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken
15. März 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou
30. August 2018 / Blood Oncogene-specific T cells fail to eradicate lymphoma-initiating B cells in mice D. Hoser C. Schön C. Loddenkemper P. Lohneis A.A. Kühl T. Sommermann T. Blankenstein G. Willimsky
01. Juni 2018 / Cancer Res ERAP1-dependent antigen cross-presentation determines efficacy of adoptive T cell therapy in mice K. Schmidt C. Keller A.A. Kühl A. Textor U. Seifert T. Blankenstein G. Willimsky P.M. Kloetzel
01. August 2018 / Clin Cancer Res Targeting Merkel cell carcinoma by engineered T cells specific to T-antigens of Merkel cell polyomavirus I. Gavvovidis M. Leisegang G. Willimsky N.J. Miller P. Nghiem T. Blankenstein
01. Januar 2018 / Cancer Immunol Res A transgenic dual-luciferase reporter mouse for longitudinal and functional monitoring of T cells in vivo M. Szyska S. Herda S. Althoff A. Heimann J. Russ D. D'Abundo T.M. Dang I. Durieux B. Dörken T. Blankenstein I.K. Na
01. August 1993 / Br J Haematol Lymphotoxin, tumour necrosis factor and interleukin-6 gene transcripts are present in Hodgkin and Reed-Sternberg cells of most Hodgkin's disease cases H.D. Foss H. Herbst E. Oelmann J. Samol M. Grebe T. Blankenstein J. Matthes Z. Qin B. Falini S. Pileri T. Diamantstein H. Stein
15. September 1993 / Canc Res Interleukin 10 transfected into Chinese hamster ovary cells prevents tumor growth and macrophage infiltration G. Richter S. Krueger-Krasagakes G. Hein C. Huels E. Schmitt T. Diamantstein T. Blankenstein
01. Juli 1993 / J Exp Med Expression of tumor necrosis factor by different tumor cell lines results either in tumor suppression or augmented metastasis Z. Qin S. Krueger-Krasagakes U. Kunzendorf H. Hock T. Diamantstein T. Blankenstein